title: A comparison of organs at risk doses in GYN intracavitary brachytherapy for different tandem lengths and bladder volumes.
abstract: The purpose of this study was to investigate the concurrent effects of tandem length and bladder volume on dose to pelvic organs at risk (OARs) in HDR intracavitary brachytherapy treatment of cervical cancer. Twenty patients with locally advanced cervical cancer were selected for brachytherapy using Rotterdam applicators. The patients were CT scanned twice with empty and full bladder. Two treatment plans were prepared on each of the image sets. Patients were categorized into two groups; those treated with a tandem length of 4 cm or smaller (T ≤ 4 cm) and those with tandem length larger than 4 cm (T > 4 cm). Only one tandem tip angle of 30° was studied. Dose-volume histograms (DVHs) of OARs were calculated and compared. Bladder dose was significantly affected by both bladder volume and tandem physical length for T ≤ 4 cm. This was reflected on the values obtained for D2cm³, D1cm³, and D0.1cm³ for both empty and full bladder cases. When T > 4 cm, no correlation could be established between variations in bladder dose and blad-der volume. Rectum dose was generally lower when the bladder was empty and T > 4 cm. Dose to sigmoid was increased when T > 4 cm; this increase was larger when the bladder was full. Our results suggest that, for tandems longer than 4 cm, keeping the bladder empty may reduce the dose to rectum and sigmoid. This is contrary to cases where a shorter than 4 cm tandem is used in which a full bladder (about 50-120 cm³) tends to result in a lower dose to rectum and sigmoid. Attention should be given to doses to sigmoid with long tandem lengths, as a larger tandem generally results in a larger dose to sigmoid.
authors.affiliation: Shahid Beheshti University. z_siavashpour@sbu.ac.ir.
authors.forename: Zahra
authors.initials: Z
authors.lastname: Siavashpour
authors.forename: Mahmoud Reza
authors.initials: MR
authors.lastname: Aghamiri
authors.forename: Ramin
authors.initials: R
authors.lastname: Jaberi
authors.forename: Naser
authors.initials: N
authors.lastname: ZareAkha
authors.forename: Hamid Reza Dehghan
authors.initials: HRD
authors.lastname: Manshadi
authors.forename: Christian
authors.initials: C
authors.lastname: Kirisits
authors.forename: Mahbod
authors.initials: M
authors.lastname: Sedaghat
mesh_terms: D001918:Brachytherapy; D012809:Colon, Sigmoid / Q000528:radiation effects; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D058958:Organs at Risk / Q000528:radiation effects*; D011379:Prognosis; D011829:Radiation Dosage; D011879:Radiotherapy Dosage; D011880:Radiotherapy Planning, Computer-Assisted / Q000379:methods; D050397:Radiotherapy, Intensity-Modulated; D012007:Rectum / Q000528:radiation effects; D001743:Urinary Bladder / Q000528:radiation effects*; D002583:Uterine Cervical Neoplasms / Q000532:radiotherapy*